Ticker ASND – Ascendis Pharma AS – sales, description, marketcap – Tickerday.com

ASND

Ascendis Pharma AS

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 8.05B; Volume: 30.34K; AvgVol 3m: 205.76K; Beta: 0.82;

Cost estimate:

P/E: –; EPS: -6.44; EPS growth quarter/prev quarter: -57.80%;

EPS growth this year: -48.00%; EPS growth past 5 years: -61.90%;

EPS ttm: -6.46;

P/S: 850.63; P/B: 13.93; P/Cashflow: 15.20; P/FCF: ;

Sales: 185.24K; Sales growth quarter/prev quarter: -56.30%; Sales growth past 5 years: -0.90%;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -40.70%; ROE – return on equity: -46.20%; LT Debt/Equity: 0.06; Total Debt/Equity: 0.07;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 1.36%; Insider Transactions:0.00%;

Institutional Ownership: 92.50%; Institutional Transactions: 0.67%;

Data update: 07/10/2020.